Yutiq 0.18 MG Drug Implant
TRA-TYNI-22-001
Phase 3 small_molecule active
Quick answer
Yutiq 0.18 MG Drug Implant for Uveitis is a Phase 3 program (small_molecule) at ANI PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ANI PHARMACEUTICALS INC
- Indication
- Uveitis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active